Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes trial The SOUL Study orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes trial The SOUL Study ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes trial The SOUL Study, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes trial The SOUL Study in your area.
Effects of Oral Semaglutide on Heart Failure Outcomes in SOUL
27.55
A secondary analysis of the SOUL trial showed that oral semaglutide, like the injected form, improves outcomes related to heart failure in high-risk patients with diabetes
23.82
Novo Nordisk's Semaglutide lowers MACE risk in SOUL trial
22.42
Congreso ACC. 25: Oral Semaglutide Reduces Cardiovascular Events in People With Type 2 Diabetes With Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial
23.61
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study | Diabetes Therapy
23.14
The impact of oral semaglutide on cardiovascular events in patients with type 2 diabetes: review of results from the SOUL trial | Heart Failure Reviews
22.60
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
29.16
